Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis. - Berning P; Maulhardt M; Boyadzhiev H; Albici AM; Janjetovic S; Ossami Saidy A; Schultze-Florey C; Call S; Stölzel F; Brioli A; Daskalakis M; Knust J; et al. (Blood cancer journal, 2026)